MAGNALAX- laxative powder, for solution

MAGNALAX by

Drug Labeling and Warnings

MAGNALAX by is a Animal medication manufactured, distributed, or labeled by Covetrus North America. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

INDICATIONS & USAGE

Antacid - laxative - absorbent

For animal use only

Keep out of reach of children

INDICATIONS

For oral adminstration to ruminants as an aid in the treatment of digestive disturbances requiring an antacid, mild laxative and absorbent.

WARNINGS AND PRECAUTIONS

Warning: Milk that has been taken from animals during treatment and for 24 hours (2 milkings) after the latest treatment must not be used for food.

Precaution: Avoid frequent or continued use.

DOSAGE & ADMINISTRATION

Dosage and administration: Mix 1 pound of magnesium hydroxide powder into 1 gallon of water and stir thoroughly. Shake well before using.Administer with a stomach tube or as a drench. 

Cattle: 1 gallon of mixture

Sheep and calves: 1 pint to 1 quart of mixture, depending on the size of animal

TAKE TIME OBSERVE LABEL INSTRUCTIONS

COMPONENTS

Composition: Each pound contains:

magnesium hydroxide ................. 10.4 oz

Flavored with capsicum, ginger and methyl salicylate.

One pound of magnesium hydroxide powder contains magnesium hydroxide equivalent to 1 gallon of mik of magnesia

STORAGE AND HANDLING

Store in a cool, dry place. 

Keep lid tightly closed when not in use.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

MAGNALAX 
laxative powder, for solution

Product Information
Product Type	OTC ANIMAL DRUG	Item Code (Source)	NDC: 11695-4151
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
MAGNESIUM HYDROXIDE (UNII: NBZ3QY004S) (MAGNESIUM CATION - UNII:T6V3LHY838)	MAGNESIUM HYDROXIDE	293.7 g  in 454 g

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 11695-4151-1	454 g in 1 JAR

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/29/2020

Labeler - Covetrus North America (603750329)